Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pancrelipase Delayed Release in PEI due to Cystic Fibrosis
NCT00510484Phase 3Completed
- Sponsor
- Solvay
- Start
- Nov 2007
- Primary completion
- Mar 2008
- Modality
- Replacement Enzymes
- Countries
- 5
01
Overview
A Phase 3 trial of pancrelipase in pancreatic exocrine insufficiency (EPI), sponsored by Solvay. Started Nov 2007; status: completed.
02
Drugs
pancrelipase
03
Conditions
pancreatic exocrine insufficiency (EPI)
Beyond the preview
Go deeper on NCT00510484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00510484.